Hualan Biological Engineering Inc(002007) vaccine Co., Ltd
Initial public offering and listing on GEM
Announcement on online subscription and winning rate
Sponsor (lead underwriter): Huatai United Securities Co., Ltd
hot tip
The application of Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. (hereinafter referred to as “Hualan vaccine”, “issuer” or “company”) for initial public offering of 40.01 million common shares (A shares) (hereinafter referred to as “this offering”) and listing on the gem has been examined and approved by the gem listing committee of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”), It has been approved to register by China Securities Regulatory Commission (hereinafter referred to as “CSRC”) (zjxk [2022] No. 2).
The issuer and the sponsor (lead underwriter) Huatai United Securities Co., Ltd. (hereinafter referred to as “Huatai United Securities”, “sponsor (lead underwriter)” or “lead underwriter”) negotiated and determined that the number of shares issued this time is 40.01 million shares, and the issue price is 56.88 yuan / share.
The issuing price of this offering shall not exceed the median and weighted average of offline investors’ quotation after excluding the highest quotation, as well as the securities investment fund, national social security fund, basic old-age insurance fund established through public offering after excluding the highest quotation The enterprise annuity fund established in accordance with the measures for the administration of enterprise annuity fund and the insurance fund quotation median and weighted average in accordance with the measures for the administration of the use of insurance funds, whichever is lower, is 62.0000 yuan / share.
According to the price of this offering, the strategic placement of this offering is a special asset management plan for the issuer’s senior managers and core employees, and the relevant subsidiaries of the sponsor do not participate in the strategic placement. The final number of strategic placement is 4001000 shares, accounting for 10.00% of the number of shares issued this time. The difference between the initial strategic placement and the final strategic placement is 2000500 shares, which are transferred back to offline issuance.
This offering will eventually adopt targeted placement to strategic investors (hereinafter referred to as “strategic placement”) Offline inquiry placement to qualified offline investors (hereinafter referred to as “offline issuance”) and online pricing issuance to social public investors holding non restricted A-Shares and non restricted depositary receipts in Shenzhen market (hereinafter referred to as “online issuance”).
After the callback of strategic placement and before the launch of online and offline callback mechanism, the initial number of offline issuance was 29207500 shares, accounting for 81.11% of the number of this issuance after deducting the final strategic placement, and the initial number of online issuance was 6801500 shares, accounting for 18.89% of the number of this issuance after deducting the final strategic placement. The total number of final offline and online issuance is 36009000 shares. The final number of online and offline issuance will be determined according to the online and offline callback.
On February 8, 2022 (t day), the issuer initially issued 6801500 A shares of “Hualan vaccine” by using the online pricing of the trading system of Shenzhen Stock Exchange.
Investors are kindly requested to focus on the issuance process, payment and other links of this issuance, and timely fulfill their payment obligations on February 10, 2022 (T + 2):
1. According to the announcement on the results of initial public offering and initial offline placement of Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. listed on the gem, the offline allocated investors shall timely and fully pay the subscription funds for new shares before 16:00 on February 10 (T + 2) 2022 according to the finally determined issuance price and initial placement quantity.
The subscription funds shall be paid in full within the specified time. If the subscription funds are not paid in full within the specified time or as required, all the new shares allocated to the placing object shall be invalid. If the above-mentioned circumstances occur when multiple new shares are issued on the same day, all the placing objects are invalid. If different placing objects share bank accounts, if the subscription funds are insufficient, all the new shares allocated to the placing objects sharing bank accounts will be invalid. Offline investors are allocated multiple new shares on the same day. Please pay for each new share separately.
After winning the lottery of new shares, online investors shall fulfill the obligation of capital settlement according to the announcement on the results of initial public offering of shares by Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. and online lottery on GEM Listing, so as to ensure that their capital account will eventually have sufficient new share subscription funds on February 10 (T + 2) 2022, and the insufficient part shall be deemed to give up the subscription, The resulting consequences and relevant legal liabilities shall be borne by the investors themselves. The transfer of investors’ funds shall comply with the relevant provisions of the securities company where the investors are located.
The shares that offline and online investors give up to subscribe for are underwritten by the sponsor (lead underwriter).
2. Among the stocks issued this time, the stocks issued online have no circulation restrictions and limited sales period arrangements, and can be circulated from the date when the stocks issued this time are listed on the Shenzhen Stock Exchange.
The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise that the sales restriction period of 10% (rounded up) of the number of shares allocated to them is 6 months from the date of the issuer’s initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, and the sales restriction period starts from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange.
When offline investors participate in the preliminary inquiry and quotation and offline purchase, they do not need to fill in the arrangement of the restricted sale period for the placing objects under their management. Once the quotation is made, it is deemed to accept the arrangement of the online restricted sale period disclosed in this announcement.
In terms of strategic placement, the issuer’s senior managers and core employees participated in the special asset management plan established by the strategic placement. The restricted period of the allocated shares is 12 months. The restricted sale period shall be calculated from the date when the shares of this public offering are listed on the Shenzhen Stock Exchange.
3. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of public offerings after deducting the final strategic placement, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
4. If the offline investor who provides effective quotation fails to participate in the subscription or the offline investor who obtains the preliminary placement fails to pay the subscription amount in time and in full, it will be deemed as a breach of contract and shall bear the liability for breach of contract. The recommendation institution (lead underwriter) shall report the breach of contract to the China Securities Association for the record. The number of violations of placing objects in various sectors of the stock market of Beijing stock exchange (hereinafter referred to as “Beijing stock exchange”), Shanghai Stock Exchange (hereinafter referred to as “Shanghai Stock Exchange”) and Shenzhen Stock Exchange shall be calculated together. During the period of being included in the restricted list, the placing object shall not participate in the offline inquiry and placement of relevant projects in all sectors of the stock market of Beijing stock exchange, Shanghai Stock Exchange and Shenzhen Stock Exchange.
If online investors fail to pay in full after winning the lottery for three times in a row within 12 months, they shall not participate in the online subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant’s latest declaration of abandonment of subscription.
The number of times of giving up subscription shall be calculated according to the number of times of investors actually giving up subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds.
1、 Online subscription
According to the data provided by Shenzhen Stock Exchange, the lead underwriter has made statistics on the effective subscription of this online offering. The number of effective subscription households of this online pricing offering is 12039937 and the number of effective subscription shares is 65375364000. The total number of allotment numbers is 130750728. The starting number of allotment number is 00000000000 1 and the ending number is 000130750728.
2、 Implementation of callback mechanism, issuance structure and success rate of online issuance
According to the callback mechanism announced in the announcement of Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. initial public offering and listing on the gem, since the initial effective subscription multiple on the Internet is 9611.90384 times, more than 100 times, the issuer and the lead underwriter decided to start the callback mechanism to adjust the scale of offline and online issuance, After deducting the final strategic placement, 20.00% (rounded up to an integral multiple of 500 shares, i.e. 7202000 shares) of the number of shares issued this time will be transferred back from offline to online. After the callback mechanism was launched, the final number of shares issued offline was 22005500, accounting for 61.11% of the number of shares issued this time after deducting the final strategic placement, and the final number of shares issued online was 14003500, accounting for 38.89% of the number of shares issued this time after deducting the final strategic placement. After the call back, the winning rate of this online issuance is 0.0214201484%, and the effective subscription multiple is 4668.50173 times.
3、 Online lottery
The issuer and the lead underwriter agreed to conduct lottery at Room 308, Shenye center, No. 5045, Shennan East Road, Luohu District, Shenzhen on the morning of February 9, 2022 (T + 1), and will publish the online lottery results in China Securities News, securities times, Shanghai Securities News and Securities Daily on February 10, 2022 (T + 2). Issuer: Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. sponsor (lead underwriter): Huatai United Securities Co., Ltd. February 9, 2022 (there is no text on this page, which is Hualan Biological Engineering Inc(002007) ) Vaccine Co., Ltd. initial public offering of shares and listing on the gem (seal page of announcement on online subscription and winning rate)
Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. (there is no text on this page, which is the seal page of the announcement on the online subscription and winning rate of Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. in its initial public offering and listing on the GEM)
Huatai United Securities Co., Ltd
